Real-World Molecular Testing Rates and Patterns in Patients With Primary Advanced or Recurrent Endometrial Cancer in the United States.

JCO Precis Oncol · 2025 · PMC11974621 · PMID 40153685

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an encouraging trendno p-value reported

Receipt of biomarker testing before surgery is an encouraging trend that indicates more patients have test results available to aid in decision making before systemic treatment initiation.

also in 151 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.